脑性瘫痪是出生时期非进行性脑损伤所导致的结果，引起运动功能障碍、肌张力增高以及不同程度的认知或感觉障碍。干细胞研究针对神经保护和神经可塑性：胎盘间充质干细胞因其抗炎作用而被研究，可能限制继发性神经元损失并减少肌张力增高，而神经源性细胞则被探索以支持受损的运动回路和突触重组。由于脑损伤是固定的，干预目标是限制继发性伤害并增强可塑性，而非逆转已建立的损伤。临床试验招募儿童和年轻成人；报告的结果包括肌张力增高的减少和运动功能的改变，通常同时伴随强化物理治疗。
四十一项注册试验和2项招募研究调查脑性瘫痪中的干细胞方法，主要在亚洲和拉丁美洲进行。小样本研究描述3-12个月内肌张力降低和大运动功能评分改善；大多数缺乏足够的对照或盲法。康复中的安慰剂效应很大，且同时进行的物理治疗使因果关系难以判断。没有大型随机对照试验证明干细胞优于强化物理治疗或既有治疗方法；少数研究持续超过12个月的随访。
欧洲成本的指示性价格大约是€4,000–€7,500/疗程。儿科输液增加了安全监测，通常采用数周内多次小剂量给药。某些方案将强化康复纳入其中，进一步增加成本。作为参考，物理治疗、肉毒杆菌毒素和矫形手术是既有的、通常由保险覆盖的治疗手段——干细胞数字仅供参考且疗效未证。
Cell therapy for Cerebral Palsy is offered as an individualised, physician-led programme. In the EU and US it is regulated as an advanced therapy rather than an approved 'cure' for this condition — it is currently 研究性. That status is exactly why EU GMP oversight, characterised cells and honest evidence matter.
Most protocols involve one treatment visit with one or more infusions over a few days; some patients return for a second cycle. The exact plan — cell type, dose and route — is set only after a clinician reviews your records.
Eligibility depends on condition stage, age and overall health. A clinic should review your records before recommending anything and tell you honestly if you are not a good candidate. Our candidacy self-check gives an indicative read in 60 seconds.
An indicative Cerebral Palsy programme is €3,000–€8,000 for treatment (it varies by procedure). Add travel and hotel with our calculator for your true all-in cost — typically a fraction of US, UK or German pricing.
We link primary regulators, registries and peer-reviewed research so you can verify everything yourself — plus the treating clinic's own materials.
位于欧盟核心的 GMP 认证再生医学诊所——费用 3,000–8,000 欧元起，仅为美国或德国价格的一小部分。为来自 50 多个国家的国际患者提供个性化方案。
免费医疗评估